Private capital markets
As institutional investors ourselves, we make it our business to understand the needs and expectations of investors.
Convergence’s team have deployed over $20 billion across an extensive range of assets from early stage venture, ILS and other alternative assets to large real-asset projects, and have sat on trading desks globally including in Brisbane, Sydney, London, Tokyo & New York.
We also have a long history of backing our judgment personally. Our team members have founded and managed multiple companies and backed numerous small companies as angel investors.
Small-cap IPO readiness
Companies with valuations over $15m are of interest to small-cap fund managers and individual share market investors alike.
We are currently assisting clients who are working towards IPO.
We can talk to you about investing in these companies pre-IPO or if you are a founder, help you work towards IPO readiness.
Insurance Linked Securities (ILS)
The team at Convergence Capital has been advising on and managing ILS strategies for over a decade.
Convergence is the only advisor in Australia and New Zealand with direct experience in sourcing, managing, reviewing and structuring investment vehicles into the ILS asset class.
Because big ideas make a big difference
Whether you are a company that needs capital to grow, or an investor who is looking to deploy a specific portfolio, Convergence Capital is there to help you.
Convergence Capital holds Wholesale AFSL no. 503221.